Assessing Rates of Hypoglycemia as an End Point in Clinical Trials
Muchmore DB, Heinemann L, Tamborlane W, Wu XW, Fleming A. Assessing Rates of Hypoglycemia as an End Point in Clinical Trials. Diabetes Care 2015, 38: e160-e161. PMID: 26283738, DOI: 10.2337/dc15-0808.Peer-Reviewed Original ResearchBlood GlucoseBlood Glucose Self-MonitoringClinical Trials as TopicEndpoint DeterminationHumansHypoglycemia